Skip to main content
helpful materials; man in middle of “V”

Supportive resources for your PLUVICTO journey

Here are some materials you can use to learn more about PSMA+ mCRPC and PLUVICTO. You can download, print, and revisit them at any stage in your or your loved ones' treatment.

For those thinking about treatment with PLUVICTO:
Considering Pluvicto Digital Pamphlet Thumbnail

When You’re Considering PLUVICTO

Information to help potential PLUVICTO patients and care partners along their treatment journey.
Download
Tk

When You're Considering PLUVICTO – Spanish

Download
Tk

When You’re the Care Partner of Someone Considering PLUVICTO

Information to help potential PLUVICTO care partners support their loved ones along their treatment journey. Coming Soon
Download
discussion guide thumbnail

A Guide for Talking With Your Doctor

Make the most of your time with your doctor. Inside are sample questions to ask during your next doctor’s visit to help you explore whether PLUVICTO is right for you.
Download
Spanish discussion guide thumbnail

A Guide for Talking With Your Doctor - Spanish

Download
For those already taking PLUVICTO:
Pluvicto vision patient brochure thumbnail

A Comprehensive Brochure for Patients and Care Partners

Information to help patients and care partners learn more about treatment with PLUVICTO.
Download
Tk

A Comprehensive Brochure for Patients and Care Partners – Spanish

Download
Tk

A Comprehensive Brochure for Patients and Care Partners – Chinese

Download
Tk

Educational Resources Flashcard

An overview of the support available during your treatment, including help with coverage, financial assistance, and access to education resources.
Download
Thumbnail of PLUVICTO Post-Treatment Guidelines

PLUVICTO Post-Treatment Guidelines

Post-treatment guidelines for patients and care partners.
Download
PLUVICTO Treatment Safety Instructions

PLUVICTO Post-Treatment Guidelines – Spanish

Download
PLUVICTO Treatment Safety Instructions

PLUVICTO Post-Treatment Guidelines – Chinese

Download
mCRPC, metastatic castration-resistant prostate cancer; PSMA+, prostate-specific membrane antigen positive.